Immunohistochemistry staining results revealed a correlation among PRMT7, FAK Y397 and cortactin Y421 phosphorylation levels, and the clinical aggressiveness of breast cancer (Figure 8E,F and Figure 8—figure supplement 1). Here, CTTN is linked to breast cancer.